First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial.

British Journal of Cancer
Ó ArrietaJ F Corona-Cruz

Abstract

Chemotherapy based on platinum is the standard treatment for unresectable malignant pleural mesothelioma (MPM). Liposomal doxorubicin (LD) consists of pegylated phospholipid vesicles that encapsulate doxorubicin-enhancing liposome deposition in the tumour. We evaluated the toxicity profile and anti-tumour activity of cisplatin plus LD in untreated patients with MPM, as well as (99m)Tc-LD distribution in MPM lesions after chemotherapy administration. A total of 38 patients with non-resectable MPM received LD 40 mg m(-2) and cisplatin 60 mg m(-2) every 21 days. Gamma camera images of (99m)Tc-LD were acquired to evaluate LD accumulation in measurable tumour tissue. The study was registered in Clinical Trials (NCT00886028). In all, 72% of patients were stage III and 28% were stage IV. Eighty four percent and 16% have high and low risk acording EORTC respectively. The median time to progression was 4.6 months (95% confidence interval (95% CI: 3.4-5.9 months), and median overall survival (OS) was 19.6 months (15.2-37.2 months). Patients that responded to chemotherapy treatment had better survival than patients who did not. Functional physical scales, dysnea, cough, and chest/arm pain demonstrated improvement. The accumulation ratio o...Continue Reading

References

Jul 24, 1980·The New England Journal of Medicine·K H Antman
Jan 1, 1982·American Journal of Industrial Medicine·W J NicholsonI J Selikoff
Jul 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B UzielyA Gabizon
Aug 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A P ChahinianL Leone
Feb 1, 1997·American Journal of Epidemiology·B Price
Feb 1, 1997·The Annals of Thoracic Surgery·E H BaldiniD J Sugarbaker
Aug 15, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P BaasG Giaccone
Aug 29, 2002·Cancer Investigation·Keith M Skubitz
Oct 26, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·T BerghmansJ P Sculier
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicholas J VogelzangPaolo Paoletti
Nov 12, 2003·The Journal of Pharmacology and Experimental Therapeutics·Ande BaoWilliam T Phillips
Feb 5, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M J Byrne, A K Nowak
Jun 1, 2005·American Journal of Clinical Oncology·Bruno CastagnetoG Sinaccio
Mar 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David C HodgsonLois B Travis
Apr 13, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·W WederUNKNOWN Swiss Group for Clinical Cancer Research
Sep 5, 2008·Current Treatment Options in Oncology·Hedy Lee Kindler
Nov 4, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Gunnar HillerdalAnders Hjerpe
Feb 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marc de PerrotMichael R Johnston
Apr 22, 2009·The Annals of Thoracic Surgery·Tristan D YanBrian C McCaughan
Sep 9, 2009·Chest·Mandira Ray, Hedy Lee Kindler
May 31, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ronan Joseph KellyRaffit Hassan

❮ Previous
Next ❯

Citations

Oct 12, 2012·OncoTargets and Therapy·Paul ZarogoulidisKonstantinos Zarogoulidis
Oct 8, 2013·Current Opinion in Oncology·Jonathan S RinkC Shad Thaxton
Feb 2, 2019·Thoracic Cancer·Leonardo RojasUNKNOWN on behalf CLICaP
May 26, 2020·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Isabelle OpitzGiuseppe Cardillo
Jun 28, 2020·European Journal of Hospital Pharmacy. Science and Practice·Yao ZhuXiaoling Zheng
May 27, 2020·The European Respiratory Journal·Arnaud ScherpereelPaul Martin Putora
Aug 6, 2020·International Journal of Molecular Sciences·Stefano BurgioCeleste Caruso Bavisotto
Oct 28, 2017·Nature Reviews. Materials·Hongmin ChenXiaoyuan Chen
Jan 31, 2018·Proceedings of the National Academy of Sciences of the United States of America·Therese TriemerNathan W Luedtke
Mar 17, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Helen LeeBart S Hendriks
Oct 27, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laurel M SchunselaarJacques Neefjes
Jun 30, 2016·Advanced Drug Delivery Reviews·Hyun Jin KimKazunori Kataoka
Jun 21, 2020·Chemistry and Physics of Lipids·Liliana Aranda-LaraKeila Isaac-Olivé
Jul 9, 2021·Apoptosis : an International Journal on Programmed Cell Death·Xiaofeng DaiJianying Zhang
Jan 10, 2017·Biomacromolecules·Nilesh Umakant Deshpande, Manickam Jayakannan

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies

Clinical Trials Mentioned

NCT00886028

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.